| Application no. and date | 07115663.2 (espacenet) (Federated) (European Patent Register), 20030303 | | Patent/reg. no. and date | DK/EP 1870100, 20120111 | | Publication date | 20071226 | | Priority no. and date | DE 10209985, 20020307, DE 10245624, 20020930 | | EP pub. no. and date |
EP 1870100 20071226 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Straße 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 156473 | | Inventor | Brauns, Ulrich, Alleenstrasse 54
88400, BIBERACH, DE,
Hauel, Norbert, Marderweg 12
88433, SCHEMMERHOFEN, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | C07D 401/12 (2006.01) | | Title | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsyre-ethylester-methansulfonat | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2012 00027 | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
